| 000 | 01279 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250516201834.0 | ||
| 264 | 0 | _c20150622 | |
| 008 | 201506s 0 0 eng d | ||
| 022 | _a1873-4286 | ||
| 024 | 7 |
_a10.2174/1381612820666140306103401 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWu, Yu-Ting | |
| 245 | 0 | 0 |
_aMetabolic reprogramming of human cells in response to oxidative stress: implications in the pathophysiology and therapy of mitochondrial diseases. _h[electronic resource] |
| 260 |
_bCurrent pharmaceutical design _c2014 |
||
| 300 |
_a5510-26 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntioxidants _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aEnergy Metabolism _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMitochondria _xdrug effects |
| 650 | 0 | 4 |
_aMitochondrial Diseases _xmetabolism |
| 650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
| 650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
| 700 | 1 | _aWu, Shi-Bei | |
| 700 | 1 | _aWei, Yau-Huei | |
| 773 | 0 |
_tCurrent pharmaceutical design _gvol. 20 _gno. 35 _gp. 5510-26 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1381612820666140306103401 _zAvailable from publisher's website |
| 999 |
_c23620191 _d23620191 |
||